Calavo Growers is engaged in marketing and distribution of avocados, prepared avocados, and other perishable food products. The company has three business segments: Fresh products, which the company sells avocados under the Calavo family of brand labels, as well as private labels and markets and distributes select other perishable food products, such as tomatoes and papayas; Calavo Foods, which utilizes ultra-high pressure technology equipment to protect and safeguard foods without the need of preservatives on several of its prepared avocado and guacamole products; and Renaissance Food Group, which creates, markets, and distributes nationally a portfolio of packaged food products.

Codexis discovers, develops and sells proteins to its clients. The company has two segments: Performance Enzymes, which uses its technology to develop enzymes for customers using next generation sequencing and polymerase chain reaction for in vitro molecular diagnostic and molecular biology research applications; and Novel Biotherapeutics, in which it has announced a global development, option and license agreement with Societe des Produits Nestle S.A. to develop CDX-6114, its own orally administrable enzyme therapeutic candidate for the potential treatment of phenylketonuria. The company's products include protein catalysts, chemical intermediates and Codex? biocatalyst panels and kits.

CorMedix is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The company's primary focus is on the development of its key product candidate, Neutrolin

First Guaranty Bancshares is a bank holding company. The company, through its subsidiary, First Guaranty Bank (the Bank), provides a range of financial services to consumers and businesses in the communities in which it operates. These services include consumer and commercial lending, mortgage loan origination, the issuance of credit cards and retail banking services. The Bank also maintains an investment portfolio comprised of government, government agency, corporate, and municipal securities. The company's key market areas include the Louisiana Market Services Areas (MSAs) of Hammond, Baton Rouge, Lafayette, and Shreveport-Bossier City along with the Texas MSAs of Dallas-Fort Worth-Arlington and Waco.

PBF Energy is a holding company. Through its subsidiaries, the company is engaged as an independent petroleum refiner and supplier of unbranded transportation fuels, heating oil, petrochemical feedstocks, lubricants and other petroleum products in the U.S. The company operates in two business segments: refining, which the company produces a variety of products at each of its refineries such as gasoline, ultra-low-sulfur diesel, heating oil, jet fuel, lubricants, petrochemicals and asphalt; and logistics, which through its PBF Logistics LP subsidiary, the company owns or leases, operates, develops and acquires crude oil and refined petroleum products terminals, pipelines, storage facilities and similar logistics assets.

Tile Shop Holdings is a holding company. Through its subsidiaries, the company is a retailer of natural stone and man-made tiles, setting and maintenance materials, and related accessories in the U.S. The company provides a range of natural stone and man-made tile products, sourced directly from its suppliers. Natural stone products include marble, travertine, granite, quartz, sandstone, slate, and onyx tiles. Man-made products include ceramic, porcelain, glass, cement, wood look, and metal tiles. The company's accessories, including trim pieces, mosaics, pencils, listellos, and other products. The company also provides a range of setting and maintenance materials, such as thinset, grout, sealers, and accessories.

Unity Biotechnology is a biotechnology company engaged in researching and developing therapeutics to extend healthspan by slowing, halting or reversing diseases of aging. UBX0101 is the company's main drug candidate for musculoskeletal disease with an initial focus on osteoarthritis of the knee. It is a small molecule inhibitor of the MDM2/p53 interaction. In addition, UBX1325 and UBX1967 are the company's main drug candidates for age-related diseases of the eye, including age-related macular degeneration, diabetic macular edema and diabetic retinopathy. These drug candidates are both senolytic small molecule inhibitor of specific members of the Bcl-2 family of apoptosis regulatory proteins.

Winnebago Industries is a manufacturer with a portfolio of recreation vehicles and marine products used primarily in leisure travel and outdoor recreation activities. The company's reportable segments include: Towable, which is comprised of products which are not motorized and are generally towed by another vehicle as well as other related manufactured products and services; and Motorhome, which is comprised of products that include a motorized chassis as well as other related manufactured products and services. The company's subsidiary, Chris-Craft USA, Inc., manufactures and sells boats in the recreational powerboat industry through a network of independent authorized dealers.